Expression and purification of amyloid-β peptides from Escherichia coli

Kanchan Garai, Scott L. Crick, Sourajit M. Mustafi, Carl Frieden

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Soluble oligomers and fibrillar deposits of amyloid beta (Aβ) are key agents of Alzheimer's disease pathogenesis. However, the mechanism of amyloid aggregation and its interaction with live cells still remain unclear requiring the preparation of large amounts of pure and different Aβ peptides. Here we describe an Escherichia coli expression system using a fusion protein to obtain either Aβ1-40 or Aβ1-42 by essentially the same procedure. The fusion protein uses a His-tagged intestinal fatty acid binding protein (IFABP) followed by a six-glycine linker and a Factor Xa cleavage site before the Aβ. The advantages of this system are that the fusion protein can be expressed in large amounts, that the fusion partner, IFABP, has been well characterized in terms of folding, that Aβ or mutated Aβ peptides can be obtained without any extra residues attached to the N-terminus and that the system can be used to incorporate fluorine-labeled amino acids. The incorporation of fluorine-labeled amino acids using auxotrophic strains is a useful NMR probe of side chain behavior. We obtain final yields of 4 and 3 mg/L of culture for Aβ1-40 and Aβ1-42, respectively.

Original languageEnglish
Pages (from-to)107-112
Number of pages6
JournalProtein Expression and Purification
Issue number1
StatePublished - Jul 2009


  • Amyloid-β
  • Expression
  • Fatty acid binding protein
  • Fusion protein


Dive into the research topics of 'Expression and purification of amyloid-β peptides from Escherichia coli'. Together they form a unique fingerprint.

Cite this